Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01805661 · ClinicalTrials.gov registry record · NA

Adductor Canal Block With Posterior Capsular Injection for Total Knee Replacement

A NA study of Pain and Osteoarthritis, sponsored by Trinity Health Of New England.

Completed
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT01805661 is a NA study of Pain and Osteoarthritis that has completed, run by Trinity Health Of New England. The registered enrollment target is 56 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01805661, a NA study of Pain and Osteoarthritis, has completed, sponsored by Trinity Health Of New England.

COMPLETED
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

To compare early ambulation and ability to participate in rehabilitation in patients undergoing total knee replacement using two different nerve block techniques for pain control. The 2 methods are 1) Adductor canal block with posterior capsular injection 2) femoral nerve block with tibial nerve block

Conditions Studied

Interventions

  • PROCEDURE Canal Block and Capsular Injection
  • PROCEDURE Femoral with Tibial Nerve Block

Study Locations (1)

Connecticut

  • Saint Francis Hospital and Medical Center - Hartford

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2013-03
Est. Completion 2013-12
Phase NA

Sponsor

Trinity Health Of New England

20 total trials

What the Registry Record Tells You About NCT01805661

The ClinicalTrials.gov registry entry for NCT01805661 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (82% lower). The listed sponsor is Trinity Health Of New England, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Canal Block and Capsular Injection is the first listed.

NCT01805661 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT01805661 about?

NCT01805661 is a clinical study titled "Adductor Canal Block With Posterior Capsular Injection for Total Knee Replacement". To compare early ambulation and ability to participate in rehabilitation in patients undergoing total knee replacement using two different nerve block techniques for pain control. The 2 methods are 1) Adductor canal block with posterior capsular injection 2) femoral nerve block with tibial nerve blo...

What is the current status of trial NCT01805661?

This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2013-03. Estimated completion is 2013-12.

What conditions does trial NCT01805661 study?

This clinical trial studies the following conditions: Pain, Osteoarthritis.

What interventions are being tested in trial NCT01805661?

The interventions under investigation include: Canal Block and Capsular Injection (PROCEDURE), Femoral with Tibial Nerve Block (PROCEDURE).

Who is sponsoring clinical trial NCT01805661?

This trial is sponsored by Trinity Health Of New England, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01805661 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.